Treace Medical Concepts, Inc. Current Liabilities
Treace Medical Concepts, Inc. (TMCI) had Current Liabilities of $41.50 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $41.50M.
- 2026-03-31: Liabilities, Current $34.49M.
- 2025-12-31: Liabilities, Current $30.64M.
- 2025-09-30: Liabilities, Current $40.91M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $41.50M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $34.49M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $30.64M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $40.91M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $41.90M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $33.18M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $34.92M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $38.26M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $44.45M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $47.05M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $45.03M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $33.15M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $30.02M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $23.30M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $30.25M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $22.58M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $16.64M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $15.38M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $18.21M 10-K · filed 2023-03-08 | |
| 2021-09-30 | $10.72M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $9.87M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $8.59M 10-Q · filed 2021-05-25 | |
| 2020-12-31 | $11.60M 10-K · filed 2022-03-04 | $11.60M 10-Q · filed 2021-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |